InvestorsHub Logo

Saltz

01/23/20 7:18 PM

#53522 RE: MrGuru #53520

Agreed. Obviously this is a potentially humongous next couple of months.

Amatuer17

01/23/20 7:34 PM

#53524 RE: MrGuru #53520

10 out of 10 will be a miracle and I don’t believe that miracles happen in science.

However even if we get 50% of patients going to CTC near zero - it will be great result - however he will have to show than in larger sample - minimum 50 patients.

There is also downside - he is showing great confidence to over confidence by going in basket trial. That is a gamble.
The CCR5 existence and impact in different types of cancer will be different. So in basket trial, the results are likely to be mixed and most likely to be inferior.

As mTNBC is showing great results, he should get basket trial protocol approved but not start the trial. Milk the mTNBC results as much as possible, move it further and then start enrollment in basket trial.
( I remember GALT trial on cancer in Standford - The TLR agonist did show some great results in 100% sample but very small number - as the time increased and sample increased - the results waned and now it is out of trial)

The patient 3-4 results are

LOL83001

01/23/20 7:46 PM

#53526 RE: MrGuru #53520

Guess I may have to ship Depends to FDA as well.